» Articles » PMID: 30191013

Hepatic Stem Cells and Cancers: a Pathologist's View

Overview
Journal Hepat Oncol
Date 2018 Sep 8
PMID 30191013
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Neil Theise is a diagnostic liver pathologist, adult stem cell researcher and complexity theorist in New York City, where he is a Professor of Pathology at the Mount Sinai Beth Israel Medical Center of Icahn School of Medicine at Mount Sinai. He received his medical degree from Columbia University College of Physicians and Surgeons, where he also received his training in Anatomic Pathology. Subspecialty training was pursued in gastrointestinal (NYU), liver (Royal Free Hospital) and liver transplant (Mount Sinai, NYC) pathology. His earliest research focus was on defining the premalignant dysplastic nodules in human chronic liver disease. He revised understandings of human liver microanatomy, which in turn, led directly to identification of possible liver stem cell niches and the marrow-to-liver regeneration pathway. He is considered a pioneer of multiorgan adult stem cell plasticity. His publications on these topics in model systems and human liver stem cells have been highlighted on a record five covers of .

Citing Articles

AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis.

Kim H, Jeong M, Na D, Ryu S, Jeong E, Jung K Cell Death Dis. 2022; 13(5):469.

PMID: 35585049 PMC: 9117275. DOI: 10.1038/s41419-022-04921-7.


The cellular origins of cancer with particular reference to the gastrointestinal tract.

Alison M Int J Exp Pathol. 2020; 101(5):132-151.

PMID: 32794627 PMC: 7495846. DOI: 10.1111/iep.12364.

References
1.
Holczbauer A, Factor V, Andersen J, Marquardt J, Kleiner D, Raggi C . Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology. 2013; 145(1):221-231. PMC: 3913051. DOI: 10.1053/j.gastro.2013.03.013. View

2.
Michalopoulos G, Grompe M, Theise N . Assessing the potential of induced liver regeneration. Nat Med. 2013; 19(9):1096-7. DOI: 10.1038/nm.3325. View

3.
Brunt E, Paradis V, Sempoux C, Theise N . Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepat Oncol. 2018; 2(3):255-273. PMC: 6095308. DOI: 10.2217/hep.15.8. View

4.
Raggi C, Factor V, Seo D, Holczbauer A, Gillen M, Marquardt J . Epigenetic reprogramming modulates malignant properties of human liver cancer. Hepatology. 2014; 59(6):2251-62. PMC: 4043911. DOI: 10.1002/hep.27026. View

5.
Kuwahara R, Kofman A, Landis C, Swenson E, Barendswaard E, Theise N . The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008; 47(6):1994-2002. PMC: 2847183. DOI: 10.1002/hep.22218. View